Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: The cardiovascular health study

Circulation

Volumn 102, Issue 19 SUPPL., 2000, Pages 2335-2340

  Siscovick, D S ^a   Schwartz, S M ^a   Corey, L ^a   Grayston, J T ^a   Ashley, R ^a   Wang, S P ^a   Psaty, B M ^a   Tracy, R P ^a   Kuller, L H ^a   Kronmal, R A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Bacteria; Coronary heart disease; Myocardial infarction; Viruses

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DEATH; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HERPES SIMPLEX VIRUS 1; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

EID: 0034619486     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.19.2335     Document Type: Article

References (40)

1. Evidence for a monoclonal origin of human atherosclerotic plaques
2. Virus induced atherosclerosis
3. Viruses in the etiology of atherosclerosis
4. The pathogenesis of atherosclerosis: An update
5. Marek's disease virus-induced atherosclerosis and evidence of a herpesvirus role in the human vascular disease
6. Genetic selection, general characterization, and history of atherosclerosis-susceptible and resistant Japanese quail
7. Possible role of cytomegalovirus in atherogenesis
8. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
9. Cytomegalovirus and atherosclerosis
10. Herpesviridae in the coronary arteries and aorta of young trauma victims
11. Cytomegalovirus/herpesvirus and carotid atherosclerosis: The ARIC Study
12. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
13. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
14. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease
15. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
16. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages: The Framingham Heart Study
17. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
18. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study
19. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study
20. Infections, inflammation, and the risk of coronary heart disease
21. Prospective study of herpes simplex vires, cytomegalovirus, and risk of future myocardial infarction and stroke
22. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk of cardiovascular disease in women
23. The Cardiovascular Health Study: Design and rationale
24. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study
25. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study
26. Methodology of ECG interpretation in the Dalhousie Program: NOVACODE ECG classification procedure for clinical trials and population health surveys
27. Cardiac Infarction Injury Score: An electrocardiographic coding scheme for ischemic heart disease
28. Laboratory methods and quality control in the Cardiovascular Health Study
29. Variability in the measurement of C-reactive protein in healthy adults: Implications for reference interval and epidemiological implications
30. The use of sonography to evaluate carotid atherosclerosis in the elderly: The Cardiovascular Health Study
31. Surveillance and ascertainment oif cardiovascular events: The Cardiovascular Health Study
32. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
33. Immune responses to genital herpes infection
34. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes virus types 1 and 2 in human sera
35. Diagnostic significance of CMV serology
36. Comparison of a latex agglutination test with five other method's for determining the presence of antibody against cytomegalovirus
37. Viral activation and thrombo-atherosclerosis
38. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor
39. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression
40. Potential role of viruses in thrombosis and atherosclerosis